Status:

NOT_YET_RECRUITING

Dietary Inflammatory Potential in Young Pleople With Obesity

Lead Sponsor:

Instituto Tecnológico y de Estudios Superiores de Occidente

Conditions:

Obesity

Dietary Inflammatory Index (DII)

Eligibility:

All Genders

18-24 years

Brief Summary

The increase in adipose tissue in the young population is one of the most important and worrying public health problems because it persists in adulthood, constituting a risk factor for chronic degener...

Detailed Description

1. Background Obesity has become one of the most critical challenges in public health. It has become a global epidemic due to the exponential growth of obesity over the last 30 years, affecting de...

Eligibility Criteria

Inclusion

  • Both sexes with no gender exclusion
  • Age between 18 and 24 years
  • Body Mass Index (BMI) ≥ 30 kg/m²
  • Signed informed consent

Exclusion

  • Pregnancy or expected pregnancy within the next month
  • Women who are breastfeeding
  • Diagnosed conditions such as: diabetes mellitus, hypertension, renal or hepatic insufficiency, infectious diseases, inflammatory diseases, or any neoplastic disease
  • Conditions with dietary restrictions, such as celiac disease or history of gastric bypass surgery
  • Active alcoholism with a daily intake exceeding 50 g/day
  • Significant anticipated changes in diet or exercise within 15 days prior to the study's start
  • History of drug or medication abuse
  • Eating disorders
  • Participation in any study involving investigational products within the 3 months prior to the start of the study
  • Treatment with anti-inflammatory drugs, antibiotics, and/or antidepressants in the month prior to the study's start
  • Consumption of nutraceuticals containing prebiotics, probiotics, or immunomodulators within 15 days prior to the study's start
  • Individuals who choose to discontinue participation after the data collection process has started.
  • Individuals who do not consent to the collection of any of the required samples (blood, diet, or stool) during the data collection phase.

Key Trial Info

Start Date :

June 20 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 7 2027

Estimated Enrollment :

170 Patients enrolled

Trial Details

Trial ID

NCT06971666

Start Date

June 20 2025

End Date

January 7 2027

Last Update

May 14 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.